comparemela.com

Endocrine Today Editorial Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Top in endocrinology: FDA warns about unapproved drugs; LillyDirect model raises concerns

Top in endocrinology: FDA warns about unapproved drugs; LillyDirect model raises concerns
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Recent diabetes, obesity drug shortages reveal challenges for prescribers

Recent shortages of the type 2 diabetes therapies semaglutide and tirzepatide, widely reported in the consumer press, appear to be resolving, according to manufacturers and prescribers. Beginning in the middle of last year in the United States, but extending globally, the shortages caused numerous challenges for prescribers treating people with type 2 diabetes and with obesity.

VIDEO: How to begin to earn trust back from minoritized patients

BALTIMORE — In this video exclusive, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Sherita Hill Golden, MD, MHS, about historical drivers of health inequities in diabetes and obesity and specific actions providers can take today. Weiner is owner and clinical director of Susan Weiner Nutrition, PLLC, in North Bellmore, NY, an Endocrine Today Editorial Board member and the Diabetes in

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.